AIDSVAX B-E: Clinical Trials

3 unknown. 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	3	Unknown 3

Follow AIDSVAX B-E: new trials by email Literature Review of AIDSVAX B-E trials Research Report on AIDSVAX B-E

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study of Immune Responses Induced by a HIV Vaccine AIDSVAX B/E, AIDSVAX B/E Placebo - HIV Infections	Phase 2	Unknown	U.S. Army Medical Research and Development Command	40	2014-07-03	2019-09-19
Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E ALVAC-HIV, AIDSVAX B/E, ALVAC-HIV Placebo - HIV Infections	Phase 2	Unknown	U.S. Army Medical Research and Development Command	360	2013-09-24	2021-03-26
Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144 ALVAC-HIV, AIDSVAX B/E, ALVAC-HIV Placebo - HIV Infections	Phase 2	Unknown	U.S. Army Medical Research and Development Command	162	2012-04-01	2020-11-03

Conditions studied

HIV Infections (3)

Sponsors

U.S. Army Medical Research and Development Command (3)

Countries

Thailand (3)

Top investigators

Jintanat Ananworanich, MD, PhD (1)  ·  Nittaya Phanuphak,, MD, PhD (1)  ·  Punnee Pitisuttithum, MD, DTM&H (1)  ·  Supachai Rerks-Ngarm, MD (1)

Results publications

PMID 28235027, PMID 28329190, PMID 32035516, PMID 37256916, PMID 37260254